US Stock MarketDetailed Quotes

ELEV Elevation Oncology

Watchlist
  • 0.809
  • +0.009+1.10%
Close Aug 23 16:00 ET
  • 0.820
  • +0.011+1.37%
Post 20:01 ET
47.81MMarket Cap-1189P/E (TTM)

Elevation Oncology Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
11.48%10.96M
-15.20%9.87M
-57.34%40.34M
-57.13%7.95M
-71.66%10.92M
-51.11%9.83M
-32.99%11.64M
195.04%94.55M
92.61%18.54M
213.85%38.53M
Selling and administrative expenses
15.95%4.41M
-11.23%3.86M
-5.86%14.9M
-19.33%3.26M
-16.54%3.5M
-0.21%3.81M
14.58%4.35M
87.34%15.83M
19.56%4.04M
40.68%4.19M
-General and administrative expense
15.95%4.41M
-11.23%3.86M
-5.86%14.9M
-19.33%3.26M
-16.54%3.5M
-0.21%3.81M
14.58%4.35M
87.34%15.83M
19.56%4.04M
40.68%4.19M
Research and development costs
8.66%6.55M
-17.57%6.01M
-67.69%25.43M
-67.65%4.69M
-78.39%7.42M
-63.01%6.03M
-46.28%7.29M
233.62%78.72M
132.07%14.5M
269.33%34.34M
Operating profit
-11.48%-10.96M
15.20%-9.87M
57.34%-40.34M
57.13%-7.95M
71.66%-10.92M
51.11%-9.83M
32.99%-11.64M
-195.04%-94.55M
-92.61%-18.54M
-213.85%-38.53M
Net non-operating interest income expense
289.30%513K
137.22%115K
40.00%-300K
-271K
-309K
-500K
Non-operating interest income
----
----
290.00%3.9M
----
----
----
----
--1M
----
----
Non-operating interest expense
----
----
180.00%4.2M
----
----
----
----
--1.5M
----
----
Total other finance cost
-289.30%-513K
-137.22%-115K
----
----
----
--271K
--309K
----
----
----
Other net income (expense)
81.55%-942K
-83,833.33%-5.04M
1,680.00%356K
196.41%295K
-5,591.40%-5.11M
-185.71%-6K
900.00%20K
-3,160.00%-306K
Special income (charges)
--0
81.55%-942K
---5.11M
--0
--0
--0
---5.11M
--0
--0
--0
-Less:Restructuring and merger&acquisition
--0
--0
--5.11M
--0
--0
--0
--5.11M
--0
--0
--0
-Less:Other special charges
----
--942K
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
----
----
1,283.33%71K
1,680.00%356K
196.41%295K
----
----
-185.71%-6K
900.00%20K
-3,160.00%-306K
Income before tax
-3.41%-10.45M
37.28%-10.7M
51.95%-45.67M
58.51%-7.89M
72.64%-10.63M
49.29%-10.11M
1.28%-17.05M
-196.69%-95.06M
-97.64%-19.02M
-216.60%-38.84M
Income tax
120.00%11K
120.00%11K
20.00%30K
-64.00%9K
11K
5K
5K
25K
25K
0
Net income
-3.47%-10.46M
37.24%-10.71M
51.93%-45.7M
58.52%-7.9M
72.61%-10.64M
49.26%-10.11M
1.25%-17.06M
-196.76%-95.08M
-97.90%-19.04M
-216.60%-38.84M
Net income continuous Operations
-3.47%-10.46M
37.24%-10.71M
51.93%-45.7M
58.52%-7.9M
72.61%-10.64M
49.26%-10.11M
1.25%-17.06M
-196.76%-95.08M
-97.90%-19.04M
-216.60%-38.84M
Minority interest income
Net income attributable to the parent company
-3.47%-10.46M
37.24%-10.71M
51.93%-45.7M
58.52%-7.9M
72.61%-10.64M
49.26%-10.11M
1.25%-17.06M
-196.76%-95.08M
-97.90%-19.04M
-216.60%-38.84M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-3.47%-10.46M
37.24%-10.71M
51.93%-45.7M
58.52%-7.9M
72.61%-10.64M
49.26%-10.11M
1.25%-17.06M
-196.76%-95.08M
-97.90%-19.04M
-216.60%-38.84M
Basic earnings per share
50.00%-0.18
68.06%-0.23
67.24%-1.34
84.15%-0.13
85.03%-0.25
58.14%-0.36
2.70%-0.72
-54.92%-4.09
-97.76%-0.82
-215.09%-1.67
Diluted earnings per share
50.00%-0.18
68.06%-0.23
67.24%-1.34
84.15%-0.13
85.03%-0.25
58.14%-0.36
2.70%-0.72
-54.92%-4.09
-97.76%-0.82
-215.09%-1.67
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 11.48%10.96M-15.20%9.87M-57.34%40.34M-57.13%7.95M-71.66%10.92M-51.11%9.83M-32.99%11.64M195.04%94.55M92.61%18.54M213.85%38.53M
Selling and administrative expenses 15.95%4.41M-11.23%3.86M-5.86%14.9M-19.33%3.26M-16.54%3.5M-0.21%3.81M14.58%4.35M87.34%15.83M19.56%4.04M40.68%4.19M
-General and administrative expense 15.95%4.41M-11.23%3.86M-5.86%14.9M-19.33%3.26M-16.54%3.5M-0.21%3.81M14.58%4.35M87.34%15.83M19.56%4.04M40.68%4.19M
Research and development costs 8.66%6.55M-17.57%6.01M-67.69%25.43M-67.65%4.69M-78.39%7.42M-63.01%6.03M-46.28%7.29M233.62%78.72M132.07%14.5M269.33%34.34M
Operating profit -11.48%-10.96M15.20%-9.87M57.34%-40.34M57.13%-7.95M71.66%-10.92M51.11%-9.83M32.99%-11.64M-195.04%-94.55M-92.61%-18.54M-213.85%-38.53M
Net non-operating interest income expense 289.30%513K137.22%115K40.00%-300K-271K-309K-500K
Non-operating interest income --------290.00%3.9M------------------1M--------
Non-operating interest expense --------180.00%4.2M------------------1.5M--------
Total other finance cost -289.30%-513K-137.22%-115K--------------271K--309K------------
Other net income (expense) 81.55%-942K-83,833.33%-5.04M1,680.00%356K196.41%295K-5,591.40%-5.11M-185.71%-6K900.00%20K-3,160.00%-306K
Special income (charges) --081.55%-942K---5.11M--0--0--0---5.11M--0--0--0
-Less:Restructuring and merger&acquisition --0--0--5.11M--0--0--0--5.11M--0--0--0
-Less:Other special charges ------942K--------------------------------
Other non- operating income (expenses) --------1,283.33%71K1,680.00%356K196.41%295K---------185.71%-6K900.00%20K-3,160.00%-306K
Income before tax -3.41%-10.45M37.28%-10.7M51.95%-45.67M58.51%-7.89M72.64%-10.63M49.29%-10.11M1.28%-17.05M-196.69%-95.06M-97.64%-19.02M-216.60%-38.84M
Income tax 120.00%11K120.00%11K20.00%30K-64.00%9K11K5K5K25K25K0
Net income -3.47%-10.46M37.24%-10.71M51.93%-45.7M58.52%-7.9M72.61%-10.64M49.26%-10.11M1.25%-17.06M-196.76%-95.08M-97.90%-19.04M-216.60%-38.84M
Net income continuous Operations -3.47%-10.46M37.24%-10.71M51.93%-45.7M58.52%-7.9M72.61%-10.64M49.26%-10.11M1.25%-17.06M-196.76%-95.08M-97.90%-19.04M-216.60%-38.84M
Minority interest income
Net income attributable to the parent company -3.47%-10.46M37.24%-10.71M51.93%-45.7M58.52%-7.9M72.61%-10.64M49.26%-10.11M1.25%-17.06M-196.76%-95.08M-97.90%-19.04M-216.60%-38.84M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -3.47%-10.46M37.24%-10.71M51.93%-45.7M58.52%-7.9M72.61%-10.64M49.26%-10.11M1.25%-17.06M-196.76%-95.08M-97.90%-19.04M-216.60%-38.84M
Basic earnings per share 50.00%-0.1868.06%-0.2367.24%-1.3484.15%-0.1385.03%-0.2558.14%-0.362.70%-0.72-54.92%-4.09-97.76%-0.82-215.09%-1.67
Diluted earnings per share 50.00%-0.1868.06%-0.2367.24%-1.3484.15%-0.1385.03%-0.2558.14%-0.362.70%-0.72-54.92%-4.09-97.76%-0.82-215.09%-1.67
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg